Prognostic impact of prostate-specific antigen at 6 months after radiotherapy in localized prostate cancer: An individual patient data analysis of randomized trials
PURPOSE We sought to evaluate the prognostic impact of prostate-specific antigen (PSA) at
6 months after completion of radiotherapy (RT) in patients treated with RT alone, RT plus …
6 months after completion of radiotherapy (RT) in patients treated with RT alone, RT plus …
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials.
L Kwak, P Ravi, JG Armstrong… - Journal of Clinical …, 2024 - europepmc.org
Purpose We sought to evaluate the prognostic impact of prostate-specific antigen (PSA) at 6
months after completion of radiotherapy (RT) in patients treated with RT alone, RT plus short …
months after completion of radiotherapy (RT) in patients treated with RT alone, RT plus short …
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials
L Kwak, P Ravi, JG Armstrong… - Journal of clinical … - pubmed.ncbi.nlm.nih.gov
Purpose We sought to evaluate the prognostic impact of prostate-specific antigen (PSA) at 6
months after completion of radiotherapy (RT) in patients treated with RT alone, RT plus short …
months after completion of radiotherapy (RT) in patients treated with RT alone, RT plus short …
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials
L Kwak, P Ravi, JG Armstrong… - Journal of Clinical …, 2024 - discovery.ucl.ac.uk
PURPOSE: We sought to evaluate the prognostic impact of prostate-specific antigen (PSA)
at 6 months after completion of radiotherapy (RT) in patients treated with RT alone, RT plus …
at 6 months after completion of radiotherapy (RT) in patients treated with RT alone, RT plus …